Newsroom

In This Section

News Release

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)

Print Page | RSS Feeds | Email Alerts

Building On Our Heritage

More than 150 years of quality, integrity and service.

Learn More

Join Us

Invest in your own career with Mallinckrodt and let’s do something dynamic together..

Learn How